ID   PDE3A_RAT               Reviewed;        1141 AA.
AC   Q62865;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 161.
DE   RecName: Full=cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A {ECO:0000250|UniProtKB:Q14432};
DE            EC=3.1.4.17 {ECO:0000250|UniProtKB:Q14432};
DE   AltName: Full=Cyclic GMP-inhibited phosphodiesterase A;
DE            Short=CGI-PDE A;
GN   Name=Pde3a {ECO:0000312|RGD:61942};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Adipose tissue;
RX   PubMed=9631240; DOI=10.1007/bf02737830;
RA   He R., Komas N., Ekholm D., Murata T., Taira M., Hockman S.C., Degerman E.,
RA   Manganiello V.C.;
RT   "Expression and characterization of deletion recombinants of two cGMP-
RT   inhibited cyclic nucleotide phosphodiesterases (PDE-3).";
RL   Cell Biochem. Biophys. 29:89-111(1998).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Cyclic nucleotide phosphodiesterase with specificity for the
CC       second messengers cAMP and cGMP, which are key regulators of many
CC       important physiological processes. Has also activity toward cUMP.
CC       Independently of its catalytic activity it is part of an E2/17beta-
CC       estradiol-induced pro-apoptotic signaling pathway. E2 stabilizes the
CC       PDE3A/SLFN12 complex in the cytosol, promoting the dephosphorylation of
CC       SLFN12 and activating its pro-apoptotic ribosomal RNA/rRNA ribonuclease
CC       activity. This apoptotic pathway might be relevant in tissues with high
CC       concentration of E2 and be for instance involved in placenta
CC       remodeling. {ECO:0000250|UniProtKB:Q14432}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a nucleoside 3',5'-cyclic phosphate + H2O = a nucleoside 5'-
CC         phosphate + H(+); Xref=Rhea:RHEA:14653, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57867, ChEBI:CHEBI:58464; EC=3.1.4.17;
CC         Evidence={ECO:0000250|UniProtKB:Q14432};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14654;
CC         Evidence={ECO:0000250|UniProtKB:Q14432};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',5'-cyclic AMP + H2O = AMP + H(+); Xref=Rhea:RHEA:25277,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:58165,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:Q14432};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:25278;
CC         Evidence={ECO:0000250|UniProtKB:Q14432};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',5'-cyclic GMP + H2O = GMP + H(+); Xref=Rhea:RHEA:16957,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57746,
CC         ChEBI:CHEBI:58115; Evidence={ECO:0000250|UniProtKB:Q14432};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16958;
CC         Evidence={ECO:0000250|UniProtKB:Q14432};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',5'-cyclic UMP + H2O = H(+) + UMP; Xref=Rhea:RHEA:70575,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57865,
CC         ChEBI:CHEBI:184387; Evidence={ECO:0000250|UniProtKB:Q14432};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70576;
CC         Evidence={ECO:0000250|UniProtKB:Q14432};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:Q14432};
CC       Note=Binds 2 divalent metal cations per subunit.
CC       {ECO:0000250|UniProtKB:Q14432};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q14432};
CC       Note=Binds 2 divalent metal cations per subunit.
CC       {ECO:0000250|UniProtKB:Q14432};
CC   -!- SUBUNIT: Homodimer. Interacts with PDE3A; direct low affinity
CC       interaction which is stimulated by binding of 17beta-estradiol/E2 to
CC       PDE3A and that positively regulates the ribonuclease activity of
CC       SLFN12. {ECO:0000250|UniProtKB:Q14432}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q9Z0X4}; Multi-
CC       pass membrane protein {ECO:0000255}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q14432}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase family.
CC       PDE3 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U38179; AAA84964.1; -; mRNA.
DR   RefSeq; NP_059033.1; NM_017337.1.
DR   AlphaFoldDB; Q62865; -.
DR   SMR; Q62865; -.
DR   BioGRID; 248419; 2.
DR   IntAct; Q62865; 1.
DR   STRING; 10116.ENSRNOP00000032282; -.
DR   PhosphoSitePlus; Q62865; -.
DR   PaxDb; 10116-ENSRNOP00000032282; -.
DR   Ensembl; ENSRNOT00000032843.2; ENSRNOP00000032282.1; ENSRNOG00000025042.2.
DR   Ensembl; ENSRNOT00055015488; ENSRNOP00055012404; ENSRNOG00055009149.
DR   Ensembl; ENSRNOT00060012660; ENSRNOP00060009597; ENSRNOG00060007660.
DR   Ensembl; ENSRNOT00065018786; ENSRNOP00065014358; ENSRNOG00065011553.
DR   GeneID; 50678; -.
DR   KEGG; rno:50678; -.
DR   UCSC; RGD:61942; rat.
DR   AGR; RGD:61942; -.
DR   CTD; 5139; -.
DR   RGD; 61942; Pde3a.
DR   eggNOG; ENOG502QSV8; Eukaryota.
DR   GeneTree; ENSGT00940000156628; -.
DR   HOGENOM; CLU_008844_0_0_1; -.
DR   InParanoid; Q62865; -.
DR   OMA; VNPDSWN; -.
DR   OrthoDB; 5479253at2759; -.
DR   PhylomeDB; Q62865; -.
DR   TreeFam; TF329631; -.
DR   Reactome; R-RNO-418555; G alpha (s) signalling events.
DR   SABIO-RK; Q62865; -.
DR   PRO; PR:Q62865; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000025042; Expressed in heart and 17 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; ISO:RGD.
DR   GO; GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; ISO:RGD.
DR   GO; GO:0004114; F:3',5'-cyclic-nucleotide phosphodiesterase activity; ISO:RGD.
DR   GO; GO:0004119; F:cGMP-inhibited cyclic-nucleotide phosphodiesterase activity; ISO:RGD.
DR   GO; GO:0004112; F:cyclic-nucleotide phosphodiesterase activity; TAS:RGD.
DR   GO; GO:0099130; F:estrogen binding; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030284; F:nuclear estrogen receptor activity; ISO:RGD.
DR   GO; GO:0097190; P:apoptotic signaling pathway; ISS:UniProtKB.
DR   GO; GO:0019933; P:cAMP-mediated signaling; ISO:RGD.
DR   GO; GO:0071321; P:cellular response to cGMP; ISO:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; ISO:RGD.
DR   GO; GO:0019934; P:cGMP-mediated signaling; ISO:RGD.
DR   GO; GO:0106072; P:negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0043951; P:negative regulation of cAMP-mediated signaling; IMP:RGD.
DR   GO; GO:0043116; P:negative regulation of vascular permeability; ISO:RGD.
DR   GO; GO:0048599; P:oocyte development; ISO:RGD.
DR   GO; GO:0001556; P:oocyte maturation; IEP:RGD.
DR   GO; GO:0060282; P:positive regulation of oocyte development; ISO:RGD.
DR   GO; GO:0043117; P:positive regulation of vascular permeability; ISO:RGD.
DR   GO; GO:0040020; P:regulation of meiotic nuclear division; ISO:RGD.
DR   GO; GO:0060700; P:regulation of ribonuclease activity; ISS:UniProtKB.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISO:RGD.
DR   CDD; cd00077; HDc; 1.
DR   Gene3D; 1.10.1300.10; 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain; 1.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR036971; PDEase_catalytic_dom_sf.
DR   InterPro; IPR023174; PDEase_CS.
DR   PANTHER; PTHR11347; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; 1.
DR   PANTHER; PTHR11347:SF104; PHOSPHODIESTERASE; 1.
DR   Pfam; PF00233; PDEase_I; 1.
DR   SMART; SM00471; HDc; 1.
DR   SUPFAM; SSF109604; HD-domain/PDEase-like; 1.
DR   PROSITE; PS00126; PDEASE_I_1; 1.
DR   PROSITE; PS51845; PDEASE_I_2; 1.
PE   1: Evidence at protein level;
KW   cAMP; cGMP; Cytoplasm; Hydrolase; Isopeptide bond; Magnesium; Manganese;
KW   Membrane; Metal-binding; Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..1141
FT                   /note="cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A"
FT                   /id="PRO_0000198801"
FT   TRANSMEM        62..82
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        127..147
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        157..177
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        182..202
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        207..227
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        229..249
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          674..1093
FT                   /note="PDEase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01192"
FT   REGION          1..41
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          89..111
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          262..309
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          433..479
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          504..643
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          669..1141
FT                   /note="Interaction with SLFN12"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   REGION          1024..1062
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1098..1141
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        433..448
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        533..551
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        608..636
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1031..1052
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1098..1115
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1116..1135
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        752
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:O76083"
FT   BINDING         752
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   BINDING         756
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   BINDING         836
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   BINDING         837
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   BINDING         837
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   BINDING         837
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   BINDING         950
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   BINDING         950
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   BINDING         1001
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   MOD_RES         310
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   MOD_RES         492
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   MOD_RES         520
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
FT   MOD_RES         524
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0X4"
FT   MOD_RES         533
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0X4"
FT   MOD_RES         1033
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0X4"
FT   MOD_RES         1036
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0X4"
FT   CROSSLNK        1120
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14432"
SQ   SEQUENCE   1141 AA;  124301 MW;  A333DFB44F6F33F3 CRC64;
     MAVRGEAAQD WAKPGLRGPS PAPVARGDHR CRGGSPSSPR GSGCCWRALA LQPLRRSPQL
     SSALCAGSLS VLLALLVRLV GGEVGGELES SQEAAAEEEE EEGARGGVFP GPRGGAPGGG
     AQLSPWLQPA ALLFSLLCAF FWMGLCLLRA GVRLPLAVAL LAACCAGEAL VQLSLGVGDG
     RLLSLPAAGV LLSCLGGATW LVLRLRLGVL MVALTSALRT VALVSLERFK VAWRPYLAYL
     AAVLGLLLAR YAEQLLPQCS GPAPPRERFG SQSSARTKEE IPGWKRRRRS SSVVAGEMSG
     CGGKSHRRTS LPCIPREQLM GHSEWDHKRG SRGSQSGTSV TVDIAVMGEA HGLITDLLAD
     PSLPPNVCTS LRAVSNLLST QLTFQAIHKP RVNPTVTFSE NYTCSDSEEG LEKDKLAIPK
     RLRRSLPPGL LRRVSSTWTT TTSATGLPTL EPAPVRRDRS ASIKPHEAPS PSAVNPDSWN
     APVLMTLTKS RSFTSSYAVS AANHVKAKKQ NRPGGLDKIS PVPSPSSSPP QGSPTSSPVS
     GIASVQFPES PEVTTKRGPG SHRALTYTQS APDLSPQIPP SPVICSSCGR PYSQGNPADG
     PSERSGPAMQ KPNRTDDTSQ VTSDYETNNN SDSSDILQND EEAECQREPL RKASACGTYT
     PQTMIFLDKP ILAPEPLVMD NLDSIMDQLN TWNFPIFDLV ENIGRKCGRI LSQVSYRLFE
     DMGLFEAFKI PVREFMNYFH ALEIGYRDIP YHNRIHATDV LHAVWYLTTQ PIPGLPSVIG
     DHGSASDSDS DSGFTHGHMG YVFSKAYHVP DDKYGCLSGN IPALELMALY VAAAMHDYDH
     PGRTNAFLVA TSAPQAVLYN DRSVLENHHA AAAWNLFMSR PEYNFLVNLD HVEFKHFRFL
     VIEAILATDL KKHFDFVAKF NAKVNDDVGI DWTNENDRLL VCQMCIKLAD INGPAKCKDL
     HLRWTEGIAS EFYEQGDEEA SLGLPISPFM DRSAPQLANL QESFISHIVG PLCHSYDSAG
     LMPGKWVDDS DDSGDTDDPE EEEEEAETPH EEETCENSEA PRKKSFKRRR IYCQITQHLL
     QNHMMWKKVI EEEQCLSGTE NQAPDQAPLQ HSSEQIQAIK EEEEEKGKPR AEETLAPQPD
     L
//
